Synopsis:
Krishna Phoschem Limited reported a 102.24 percent YoY increase in Q2FY26 revenue and a 98 percent YoY rise in net profit, indicating strong and rapid growth.
The shares of a small-cap firm engaged in the production of fertilizers and chemical products gained attention following its Q2FY26 results and updates. With a market capitalization of Rs.3,469.66 crores, the shares of Krishna Phoschem Limited were trading at Rs.572.65, up by 0.39 percent from its previous day closing price of Rs.570.45.
Q2FY26 Results
Krishna Phoschem Limited posted revenue of Rs.607.86 crore in Q2FY26, up by 102.24 percent from Rs.300.56 crore in Q2FY25, and up by 53.68 percent compared to Rs.395.53 crore in the previous quarter.
The company’s net profit stood at Rs.33.16 crore in Q2FY26, rising to 98.08 percent from Rs.16.74 crore a year ago and up by 8.43 percent from Rs.30.58 crore in the previous quarter.
Also Read: Smallcap IT stock jumps 11% after Railway Minister Ashwini Vaishnaw endorses MapMyIndia
Other Updates
The company has recently launched three innovative fertilizer products, such as Annadata Super 6, Bharat Urea SSP, and Annadata Zibo. These new offerings are designed to provide farmers with comprehensive and convenient nutrient solutions for better crop growth and yield.
The company reported its strongest half-year performance ever, with record revenue, profit, and EPS driven by high plant utilization and strong demand for new products. Revenue more than doubled, while net profit and EPS almost doubled.
Krishna Phoschem Limited, established in 2004 and part of the Ostwal Group, is a leading player in India’s fertilizer and chemical manufacturing sector. The company produces beneficiated rock phosphate, single super phosphate, granulated SSP, and sulphuric acid.
Written By Jhanavi Sivakumar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
